Disruptive Pharma AB (publ)
556755-3226ActiveSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Biotechnology Companyguardtherapeutics.com
Oversikt
- 5–9
- Ansatte
- ≤1t SEK
- Omsetning
- 2008
- Grunnlagt
Nøkkelbeslutningstakere
Tobias L Agervald
CEO
@guardtherapeutics.com+46867XXXXX
Karin Botha
CFO
Khatereh Ahmadi
Board Member
Torbjörn Larsson
Head of Chemistry, Manufacturing and Control
+9 flere kontakter i Funnelfeedr
Beskrivelse
Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...
ASAMEDIC AS